Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.

NCT06183645 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

DEVICE: Actimyo

Sponsor

Centre Hospitalier Universitaire de Liege

Collaborators

[object Object]
[object Object]